yesafili
viatris limited - aflibercept - macular edema; retinal vein occlusion; diabetic retinopathy; myopia, degenerative; diabetes complications - szemészeti - yesafili is indicated for adults for the treatment ofneovascular (wet) age-related macular degeneration (amd) (see section 5. 1),visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo) (see section 5. 1),visual impairment due to diabetic macular oedema (dme) (see section 5. 1),visual impairment due to myopic choroidal neovascularisation (myopic cnv) (see section 5.
asentra 50 mg filmtabletta
krka d.d., - szertralin -
asentra 100 mg filmtabletta
krka d.d., - szertralin -
aurorix 150 mg filmtabletta
viatris healthcare ltd. - moklobemid -
aurorix 300 mg filmtabletta
viatris healthcare ltd. - moklobemid -
cipralex 10 mg filmtabletta
lundbeck a/s - escitalopram -
citapram 20 mg filmtabletta
sandoz hungária kft. - citalopram -
citapram 30 mg filmtabletta
sandoz hungária kft. - citalopram -
citapram 40 mg filmtabletta
sandoz hungária kft. - citalopram -
citapram 60 mg filmtabletta
sandoz hungária kft. - citalopram -